Articles

1. Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single‑dose, randomized, and double‑blind study

   • Gaute Lyngstad
   • Per Skjelbred
   • Lasse Ansgar Skoglund

   Correction Open access 24 April 2024

2. A newly developed algorithm for switching outpatient medications to medications listed in the hospital formulary: a prospective real-word evaluation in patients admitted electively to hospital

   • Finja Möller
   • Malte Oetting
   • Thilo Bertsche

   Research Open access 24 April 2024

   

3. Inconclusiveness of psychometric testing of medication adherence questionnaires

   • Isabelle Arnet
   • Christiane Eickhoff
   • Samuel S Allemann

   Research Open access 22 April 2024

4. Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis

   • Xiding Yang
   • Qiangyong Yan
   • Pingfei Fang

   Research 19 April 2024

   

5. Medication use before and during pregnancy in Japan: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study

   • Aoi Noda
   • Taku Obara
   • Shinichi Kuriyama

   Research Open access 17 April 2024

   

6. Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study

   • Xinhai Huang
   • Wenlin Xu
   • Jinhua Zhang

   Research 12 April 2024

   

7. Albumin: a comprehensive review and practical guideline for clinical use

   • Farshad Abedi
   • Batool Zarei
   • Sepideh Elyasi

   Research 12 April 2024

   

8. Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials

   • Joseph P. Rindone
   • Chadwick K. Mellen

   Review 10 April 2024

   

9. ChatGPT for generating multiple-choice questions: comment

   • Hineptch Daungsupawong
   • Viroj Wiwanitkit

   Correspondence 09 April 2024

10. Paving the way towards medicines for women and men

    • Rita Banzi
    • Silvio Garattini

    Perspective 09 April 2024

11. Poor performance of ChatGPT in clinical rule-guided dose interventions in hospitalized patients with renal dysfunction

    • Merel van Nuland
    • JaapJan D. Snoep
    • Paul D. van der Linden

    Research 09 April 2024

    

12. “Always look at the outliers”: in memoriam Leif Bertilsson

    • Julia Stingl
    • Eleni Aklillu
    • Teh Lay Kek

    Correspondence Open access 03 April 2024

    

13. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review

    • Nastaran Talaee
    • Shataw Azadvar
    • Salar Vaseghi

    Review 01 April 2024

    

14. Is “interventional trial” a correct term to use in clinical research?

    • Rafael Dal-Ré

    Correspondence 30 March 2024

15. Oral contraceptives in adolescents: a retrospective population-based study on blood pressure and metabolic dysregulation

    • Priscila Xavier de Araújo
    • Priscila Moreira
    • Maria do Carmo Franco

    Research 30 March 2024

    

16. High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease

    • Esma H. San
    • Angelique Egberts
    • Erwin C. Vasbinder

    Research 30 March 2024

    

17. Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail

    • Qian Dong
    • Chunli Chen
    • Charalambos Dokos

    Research Open access 28 March 2024

    

18. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings

    • D. Thisuri N. De Silva
    • Michael Petrovski
    • Kevin T. Batty

    Research Open access 28 March 2024

19. Failure to reduce benzodiazepine prescriptions through the implementation of a psychological intervention for insomnia in an Italian mental health service

    • Barbara D’Avanzo
    • Alberto Parabiaghi
    • Angelo Barbato

    Research 27 March 2024

    

20. Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring

    • Mervat M. Omran
    • Amel B. Ibrahim
    • Marwa S. Hamza

    Research Open access 27 March 2024

    

21. Management of enzyme de-induction in a woman with HIV on methadone maintenance switched from nevirapine- to bictegravir-based antiretroviral regimen

    • Dario Cattaneo
    • Andrea Giacomelli
    • Cristina Gervasoni

    Correspondence 25 March 2024

22. Factor Xa Inhibitors versus warfarin in patients with morbid obesity and atrial fibrillation

    • Paul Dobry
    • Kirsten McGrew
    • Christopher Giuliano

    Research 20 March 2024

    

23. High intra-patient variability of tacrolimus within post-operative 1 month predicted worse 1-year outcomes in pediatric liver transplant recipients

    • Fang Chen
    • June-Kong Yong
    • Qiang Xia

    Research 19 March 2024

    

24. Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4

    • Tianye He
    • Bicui Chen
    • Jianfei Long

    Research 19 March 2024

    

25. Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review

    • Yu Cheng
    • Yujia Zhang
    • Limei Zhao

    Review 18 March 2024

    

26. Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients

    • Mohammad Tanashat
    • Almothana Manasrah
    • Mohamed Abouzid

    Review 18 March 2024

    

27. ChatGPT for generating multiple-choice questions: a reply

    • Yavuz Selim Kıyak
    • Özlem Coşkun
    • Canan Uluoğlu

    Correspondence 14 March 2024

28. Pharmacokinetics of polymyxin B in different populations: a systematic review 

    • Xing Wang
    • Wenqiang Xiong
    • Hong Zhang

    Review 14 March 2024

    

29. Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications

    • Zhipeng Wang
    • Hongsen Wang
    • Xia Tao

    Review 14 March 2024

    

30. The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line

    • Mustafa Korkmaz
    • Melek Karakurt Eryılmaz
    • Mehmet Artaç

    Research 13 March 2024

    

31. Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany

    • Fabian Kerwagen
    • Christoph Ohlmeier
    • Stefan Störk

    Research Open access 12 March 2024

    

32. Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics

    • Pierre Marquet
    • Emilie Jouanjus
    • on behalf of the EACPT

    Research 11 March 2024

    

33. Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients

    • Anqi Zhao
    • Daihong Guo
    • An Fu

    Research 05 March 2024

    

34. Impact of combined propranolol and oxytocin on the process and outcomes of labor: a meta-analysis of randomized controlled trials

    • Xia Liu
    • Hai-Xu Chen
    • Bo Chen

    Research 04 March 2024

    

35. Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data

    • Maaike M. E. Diesveld
    • Daniëlle W. M. Jacobs- Pijnenburg
    • Sander D. Borgsteede

    Review 02 March 2024

    

36. Evaluation of methods measuring medication adherence in patients with polypharmacy: a longitudinal and patient perspective

    • Laura Mortelmans
    • Eva Goossens
    • Tinne Dilles

    Research 01 March 2024

    

37. The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review

    • Qiang Xu
    • Yanlei Sang
    • Lu Li

    Review 29 February 2024

    

38. The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism

    • Sireen Abdul Rahim Shilbayeh
    • Iman Sharaf Adeen
    • Anwar Mansour Alnakhli

    Research 29 February 2024

    

39. Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank

    • Xue-Feng Jiao
    • Hailong Li
    • Lingli Zhang

    Research Open access 28 February 2024

    

40. Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?

    • Onur Turan
    • Nalan Ogan
    • Celal Satıcı

    Research 23 February 2024

    

41. Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets

    • Kristine Hole
    • Silje K Lorentsen
    • Tore Haslemo

    Research Open access 23 February 2024

    

42. DAHOS Study: Efficacy of dapagliflozin in treating heart failure with reduced ejection fraction and obstructive sleep apnea syndrome — A 3-month, multicenter, randomized controlled clinical trial

    • Liang Xie
    • Shengnan Li
    • Jiayi Tong

    Research 22 February 2024 Pages: 771 - 780

    

43. Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis

    • Clara Oliveira
    • Beatrice Mainoli
    • João Costa

    Review Open access 19 February 2024 Pages: 677 - 684

    

44. Effectiveness of paracetamol-NSAID combinations for upper and lower respiratory tract infections: a preliminary evaluation in primary care

    • Francesco Lapi
    • Ettore Marconi
    • Claudio Cricelli

    Correspondence 17 February 2024 Pages: 781 - 783

45. A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity

    • Manmeet Kaur
    • Saurav Misra

    Review 17 February 2024 Pages: 669 - 676

    

46. Comparison of ticagrelor and clopidogrel in anemic patients with acute coronary syndrome: efficacy and safety outcomes over one year

    • Tolga Onuk
    • Fuat Polat
    • Furkan Durak

    Research 16 February 2024 Pages: 759 - 770

    

47. Exploratory associations of tacrolimus exposure and clinical outcomes after lung transplantation: A retrospective, single center experience

    • Wenwen Du
    • Xiaoxing Wang
    • Xianbo Zuo

    Research 16 February 2024 Pages: 747 - 757

    

48. Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study

    • Qian Wang
    • Pei Liang
    • Li Li

    Research Open access 14 February 2024 Pages: 737 - 746

    

49. ChatGPT for generating multiple-choice questions: Evidence on the use of artificial intelligence in automatic item generation for a rational pharmacotherapy exam

    • Yavuz Selim Kıyak
    • Özlem Coşkun
    • Canan Uluoğlu

    Research 14 February 2024 Pages: 729 - 735

50. ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics

    • Boel Nilsson
    • Johan Bylund
    • Märta Segerdahl

    Research Open access 14 February 2024 Pages: 717 - 727